Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,666 | -20,102 | -8,947 | -38,511 | -30,336 |
| Depreciation Amortization | 738 | 494 | 254 | 1,507 | 1,139 |
| Accounts payable and accrued liabilities | 289 | 30 | 303 | -291 | -208 |
| Other Working Capital | -4,133 | -1,858 | -2,552 | -1,779 | -2,807 |
| Other Operating Activity | 3,337 | 4,878 | 2,118 | 9,692 | 7,428 |
| Operating Cash Flow | $-27,435 | $-16,558 | $-8,824 | $-29,382 | $-24,784 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -16 | N/A | -208 | -139 |
| Investing Cash Flow | $-15 | $-16 | $N/A | $-208 | $-139 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,588 | -2,558 | -28 | -5,045 | -18 |
| Common Stock Issued | 73 | 13 | 13 | 3,471 | 2,548 |
| Other Financing Activity | -120 | -120 | -120 | 31,450 | 20,700 |
| Financing Cash Flow | $-2,635 | $-2,665 | $-135 | $29,876 | $23,230 |
| Beginning Cash Position | 51,181 | 51,181 | 51,181 | 50,895 | 50,895 |
| End Cash Position | 21,096 | 31,942 | 42,222 | 51,181 | 49,202 |
| Net Cash Flow | $-30,085 | $-19,239 | $-8,959 | $286 | $-1,693 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,435 | -16,558 | -8,824 | -29,382 | -24,784 |
| Capital Expenditure | -15 | -16 | N/A | -208 | -139 |
| Free Cash Flow | -27,450 | -16,574 | -8,824 | -29,590 | -24,923 |